Figure 8. Osmotin attenuated the deleterious effects of Aβ1-42 in vitro.
(A). The ApoTox-GloTM assay in neuronal HT22 cells. Cell viability was decreased but cytotoxicity and caspase-3/7 activation were increased after treatment with Aβ1-42 (5 μM) compared with the control treatment. Treatment with osmotin at three different concentrations (0.1, 0.2, or 0.4 μM) significantly reduced the effects of Aβ1-42, thereby increasing cell viability and decreasing cytotoxicity and caspase-3/7 activation. (B) The ApoTox-GloTM assay in primary hippocampal neuron cultures from GD 17.5 rat fetuses. Cell viability was decreased but cytotoxicity and caspase-3/7 activation were increased after Aβ1-42 (5 μM) treatment compared with the control treatment. Treatment with osmotin at three different concentrations (0.1, 0.2, or 0.4 μM) significantly reduced the effects of Aβ1-42, thereby increasing cell viability and decreasing cytotoxicity and caspase-3/7 activation. #significantly different from the control; *significantly different from the Aβ1-42-treated mice. Ns = not significant compared with the Aβ1-42-treated mice. n = 3 per experiment.